Aardvark Therapeutics Inc (AARD) Annual Balance Sheets

Annual · GAAP · USD millions
Access AARD quarterly Balance Sheets →
This page allows investors to track Aardvark Therapeutics Inc's balance sheet development across multiple reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Assets
Cash & cash equivalent47.05
Short-term Investments, Total62.98
Cash & Short-term Investments109.00
Prepaid Expense And Other Assets Current1.86
Total Current Assets111.89
Other Assets, Noncurrent5.30
Operating Lease Right Of Use Asset0.36
Total Assets117.18
Liabilities
Accounts Payable, Current AC2.07
Accrued Liabilities, Current AC8.04
Total Current Liabilities10.55
Total Long-term Debt0.00
Operating Lease Liability Current0.44
Total Liabilities10.55
Stockholders' Equity
Additional Paid In Capital Common Stock222.47
Retained Earnings / Accumulated Deficit-115.92
Other Equity0.08
Common Stockholder's Equity106.63
Total Stockholder's Equity106.63
Liabilities & Stockholder's Equity117.18
4 historic quarters locked

Sign in to unlock the full Aardvark Therapeutics Inc balance sheet history.

About Aardvark Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-119770

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.